Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial
Authors: Auclin, E., Andre, T., Taieb, J., Banzi, M., van Laethem, J.L., Tabernero, J., Hickish, T., de Gramont, A. and Vernerey, D.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Volume: 29
Pages: viii154
eISSN: 1569-8041
DOI: 10.1093/annonc/mdy281.010
Source: Scopus
Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial.
Authors: Auclin, E., Andre, T., Taieb, J., Banzi, M., van Laethem, J.-L., Tabernero, J., Hickish, T., de Gramont, A. and Vernerey, D.
Journal: Ann Oncol
Volume: 29 Suppl 8
Pages: viii154
eISSN: 1569-8041
DOI: 10.1093/annonc/mdy281.010
Source: PubMed
Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial
Authors: Auclin, E., Andre, T., Taieb, J., Banzi, M., van Laethem, J.-L., Tabernero, J., Hickish, T., de Gramont, A. and Vernerey, D.
Journal: ANNALS OF ONCOLOGY
Volume: 29
Pages: 154
eISSN: 1569-8041
ISSN: 0923-7534
Source: Web of Science (Lite)